Updated Jul 16, 2026
Marshall Richard Peter has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $20K.
Marshall Richard Peter is a corporate director who, according to the most recent SEC filing dated 2026-05-22, serves as a director of Serina Therapeutics, Inc. Public biographical details beyond the SEC filing context are not provided in the materials available here.
| Role | Director |
|---|---|
| Notability | 42/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | SER | Serina Therapeutics, Inc. | P — Open-market purchase | 12.2K | $1.65 | $20K |
Marshall Richard Peter is a corporate director who, according to the most recent SEC filing dated 2026-05-22, serves as a director of Serina Therapeutics, Inc. Public biographical details beyond the SEC filing context are not provided in the materials available here.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($20K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Marshall Richard Peter profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.